Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ANIX
ANIX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ANIX News
Anixa Biosciences Reports Positive Survival Data from Lira-cel Trial
May 11 2026
PRnewswire
Anixa Biosciences CEO to Appear on Bloomberg Interview
May 01 2026
PRnewswire
Anixa Biosciences CEO to Appear on Bloomberg Interview
May 01 2026
Newsfilter
Anixa Biosciences Secures New Patent for Breast Cancer Vaccine
Apr 29 2026
PRnewswire
Anixa Biosciences Secures New Patent for Breast Cancer Vaccine
Apr 29 2026
Newsfilter
Anixa Biosciences Reports Positive Phase 1 Trial Data for Lira-cel
Apr 22 2026
PRnewswire
Anixa Biosciences Reports Positive Clinical Trial Results for Cancer Vaccines
Apr 09 2026
PRnewswire
Anixa Biosciences Reports Progress on Cancer Vaccine Trials
Apr 09 2026
Newsfilter
Anixa Biosciences Advances Cancer Immunotherapy Pipeline
Apr 06 2026
PRnewswire
Anixa Biosciences Advances Cancer Immunotherapy Pipeline
Apr 06 2026
Newsfilter
Anixa Biosciences Advances Breast Cancer Vaccine Clinical Trial Following Phase 1 Success
Apr 01 2026
PRnewswire
Anixa Biosciences Advances Cancer Therapy with Lira-cel Trial Update
Mar 30 2026
PRnewswire
Anixa Biosciences Updates on CAR-T Therapy Progress
Mar 30 2026
Newsfilter
Anixa Biosciences CEO Discusses Cancer Vaccine Progress on Podcast
Mar 12 2026
Newsfilter
Anixa Biosciences CEO Discusses Cancer Vaccine Progress on Podcast
Mar 12 2026
PRnewswire
Anixa Biosciences Secures Patent Allowance in South Korea
Mar 09 2026
seekingalpha
Show More News